ACCESS PACK EXPO XPRESS ONLINE TODAY
ACCESS PACK EXPO XPRESS ONLINE TODAY. Content is available on-demand through November 30th.
LEARN MORE

Low Doses of Lithium Could be Alzheimer’s Kryptonite

Less may be more when it comes to fighting Alzheimer’s disease with lithium.

Lithium therapy to treat Alzheimer’s disease is far from a new concept, but the variation in studies has prevented definitive progress. Additionally, multiple treatments of high doses of lithium cause serious side effects, rendering the approach impractical for extended treatments, especially in older people most affected by the disease. However, a recent Science Tech Daily article suggests lower doses of lithium may be the key to halting the progression of Alzheimer’s disease.

A team of scientists at McGill University showed that lithium doses 400 times lower than what is prescribed for mood disorders can actually halt signs of advanced Alzheimer’s pathology and recover compromised cognitive abilities. The key is administering the drug in a formulation that facilitates passage to the brain. With early success, the team hopes to launch clinical trials of the formulation soon.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Access On-Demand Content Today
Discover innovative solutions for packaging and processing, automation, sustainability, e-commerce and more.
LEARN MORE
Access On-Demand Content Today